Stamos Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stamos Capital Partners's LLY Position: Q2 2026 in Review
Stamos Capital Partners reduced its Eli Lilly (LLY) stake by 11% in Q2 2026, selling an estimated $695K and leaving 5,449 shares worth $6.54M. The position accounts for 1% of the portfolio, ranked #27.
Stamos Capital Partners first reported a position in LLY in Q4 2018 and has held it in 16 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Stamos Capital Partners held 5,449 shares of Eli Lilly worth $6.54M as of Q2 2026.
- Stamos Capital Partners sold 680 Eli Lilly shares in Q2 2026, an estimated $695K.
- Eli Lilly made up 1% of Stamos Capital Partners's portfolio in Q2 2026, its #27 holding.
- Stamos Capital Partners first reported a position in Eli Lilly in Q4 2018 and has held it in 16 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Stamos Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.